Zhong Yuan Bio-Technology

Zhong Yuan Bio-Technology is a biotechnology company focused on the research, development, and commercialization of nervonic acid-based products for brain health and the treatment of neurological disorders. The company specializes in utilizing nervonic acid derived from the Acer truncatum (Purple-blow maple) tree to target conditions involving myelin sheath degradation, such as Alzheimer's and Parkinson's disease. Their business model encompasses the entire value chain, including the cultivation of raw materials, extraction of high-purity nervonic acid, and the sale of dietary supplements. Additionally, the company is engaged in clinical research to advance nervonic acid as a pharmaceutical-grade therapeutic candidate for cognitive impairment. Zhong Yuan Bio-Technology is headquartered in Hong Kong and operates through its primary subsidiary, Bao Feng Bio-Technology, in mainland China.